Navigation Links
Contract Research Organizations Set to Experience Rapid Growth as Development Costs for New Drugs Continue to Rise
Date:5/15/2012

FARMINGTON, Conn., May 15, 2012 /PRNewswire-iReach/ -- Global Information Inc. is pleased to announce two significant new reports on Drug Development:

Contract Research Organizations Market to 2018
The Contract Research Organizations industry grew at the rate of 12% from 2009 to 2010 according to GBI Research's new market research report, Contract Research Organizations Market to 2018: Public-Private Partnerships to Strengthen Research Capacities and Advance Clinical Development Programs. This April 2012 report provides a comprehensive insight into the size of the CRO market, and includes forecasts, key reasons for outsourcing, technology developments affecting CRO's, public private partnerships, profiles of top CROs, drivers and restraints and deals analysis.

All the companies are looking to cut down the time for launch of drugs along with a reduction in the expenditure on R&D. GBI research estimates that the global R&D outsourcing market in 2010 was 25.3% of the total pharmaceutical R&D expenditure. The expenditure is estimated to increase at the rate of 5% annually and is expected to reach 37.1% of the total R&D expenditure by 2018.

An Executive Summary for this report and a free sample of the full document are available at http://www.giiresearch.com/report/gbi238358-contract-research-organizations-cros-market-2018.html

Outsourcing in Drug Development: The Contract CRO, Clinical Trial Lab and EDC Market
Estimates put the cost of developing and bringing a drug to market at over $1.3 billion. As drug development may take as long as 15 years, major pharmaceutical marketers continue to outsource stages of development, creating growing demand for Contract Research Organizations (CROs). A key cost driver during the expensive clinical trial phase is the large number of failures. Driven by pressures to reduce costs, companies are increasingly implementing outsourcing strategies to increase revenues through faster drug development.

Kalorama Information's new market research report, Outsourcing in Drug Development: The Contract CRO, Clinical Trial Lab and EDC Market, studies the drivers for outsourcing drug development, the companies involved in this market, and the opportunity for revenues. The report offers Market Size and Forecasts for Outsourcing In Drug Development, market drivers and restraints; as well as profiles of CROs, clinical trial laboratories, EDC companies and site management networks.

A summary for this report and a free sample of the full document are available at http://www.giiresearch.com/report/kl225424-outsourcing-drug-development-contract-cro-clinical.html

About Global Information Inc. Global Information (GII) (http://www.giiresearch.com) is an information service company partnering with over 300 research companies around the world. Global Information has been in the business of distributing technical and market research for more than 25 years. Expanded from its original headquarters in Japan, Global Information now has offices in Korea, Taiwan, Singapore, Europe and the United States.

Media Contact: Jeremy Palaia Global Information, Inc., 1-860-674-8796, Press@gii.co.jp

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Global Information, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Bacterin International Signs Its Third National GPO Contract with Novation
2. Nonin Medical Awarded Novation Contract for Clinically Proven Pulse Oximeters
3. Novation Inks Supplier Contract Category Agreement for Masimo SET® pulse oximetry and rainbow® SET Pulse CO-Oximetry™
4. Biomedical Advanced Research and Development Authority (BARDA) Exercises Option with Pfenex Inc. To Extend Contract for the Development of a Recombinant Protective Antigen (rPA) Based Anthrax Vaccine
5. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
6. QBC Diagnostics Awarded GSA Contract
7. Prime Therapeutics Announces CareCentered Contract™ with EMD Serono, Inc. for MS Drug Rebif®
8. The Centers for Disease Control & Prevention Signs Vaccine Warehouse and Distribution Contract with Sentry BioPharma Services
9. Former Synteract CEO Unveils Non-Profit Contract Research Organization, PHACT, to Help Eliminate Neglected Diseases in Developing Countries
10. European Pharmaceutical and Biotech Contract Manufacturing Markets
11. Unity Management Group Subsidiary Announces First Contracts of 2012 with Purdue Pharma L.P. and Novartis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2017)... , Oct. 2, 2017  Eli Lilly and ... financial results for the third quarter of 2017 on ... conference call on that day with the investment community ... The conference call will begin at 9 ... can access a live webcast of the conference call ...
(Date:10/2/2017)... , Oct. 2, 2017 The Rebound mobile ... the struggle to reverse the tide of prescription drug addiction. ... regulating their medicine intake and stepping down their dosage in ... to launch in December 2017; the first 100,000 people to ... more at http://www.rebound-solution.com/ ...
(Date:9/27/2017)... , Sept. 27, 2017  Commended for their devotion to ... awards. Ranked as number one in the South Florida Business ... in Inc. 5000 yearly list, the national specialty pharmacy has ... Armando Bardisa will soon be honored by SFBJ as ... Set to receive his award in October, ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... As health professionals work to ... “patient engagement.” The patient is doing more than filling out a survey; in many ... is an increasing emphasis in health care and research on the importance of active ...
(Date:10/13/2017)... , ... October 13, 2017 , ... The American Board ... become its next President and Chief Executive Officer, succeeding Dr. James C. Puffer upon ... beginning July 1, 2018 until Dr. Puffer’s retirement at the end of 2018. Upon ...
(Date:10/13/2017)... Las Vegas, Nevada (PRWEB) , ... October 13, 2017 , ... ... of 7® Hemp CBD Oil utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum ... CBD dose required and providing a CBD form that can be easily incorporated into ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Lori R. Somekh, ... member of ElderCounsel, a national organization of elder law and special needs planning attorneys. ... and rules. It also provides a forum to network with elder law attorneys nationwide,” ...
(Date:10/13/2017)... ... 2017 , ... Many families have long-term insurance that covers care for a ... waiver for care if the client has a cognitive impairment diagnosis. , “What ... is often waived, so the benefits from their insurance start immediately,” said Mechell Vieira, ...
Breaking Medicine News(10 mins):